Reaction equation
[C:1]1([CH:7]([C:11]2[CH:16]=[CH:15][CH:14]=[CH:13][CH:12]=2)[C:8](Cl)=[O:9])[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.[CH:17]1([C:20]2[O:24][C:23]([NH2:25])=[N:22][N:21]=2)[CH2:19][CH2:18]1>>[CH:17]1([C:20]2[O:24][C:23]([NH:25][C:8](=[O:9])[CH:7]([C:11]3[CH:16]=[CH:15][CH:14]=[CH:13][CH:12]=3)[C:1]3[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=3)=[N:22][N:21]=2)[CH2:19][CH2:18]1Participants
3
Procedure
The title compound, white solid, m.p. 159-160° C. and MS: m/e=320.3 (M+H+) was prepared in accordance with the general method of example 44a from 2,2-diphenylacetic acid chloride and 5-cyclopropyl-[1,3,4]oxadiazol-2-ylamine.
Sources & evidence
- ORD record
- ord-116ce5b6c4e54960be1156bf8c2cd2f6
- Source dataset
- uspto-grants-2004_10
- Patent number
- US06803381B1
Linked notes
Loading…